Long-Term Evaluation of a Rat Model of Chronic Cholangitis Resembling Human Primary Sclerosing Cholangitis

Scandinavian Journal of Immunology

Volumn 58, Issue 5, 2003, Pages 533-540

  Goetz, M ^a   Lehr, H A ^a   Neurath, M F ^a   Galle, P R ^a   Orth, T ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HAPTEN; NEUTROPHIL CYTOPLASMIC ANTIBODY; REAGENT; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT DILATATION; BILE DUCT LIGATION; BILE DUCT OBSTRUCTION; BLOOD ANALYSIS; BLOOD CHEMISTRY; CHOLANGIOGRAPHY; CHOLANGITIS; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE MODEL; DISEASE SEVERITY; EVALUATION; FEMALE; HISTOPATHOLOGY; INJECTION; LAPAROTOMY; LIVER INJURY; MONONUCLEAR CELL; NONHUMAN; OUTCOMES RESEARCH; PREDICTION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SPLEEN CELL; SUPERNATANT;

ALANINE TRANSAMINASE; ANIMALS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; C-REACTIVE PROTEIN; CHOLANGITIS, SCLEROSING; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; HUMANS; LIVER; RATS; RATS, INBRED LEW; TRINITROBENZENESULFONIC ACID;

EID: 0242406904     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2003.01335.x     Document Type: Article

References (30)

1. Senaldi G, Donaldson PT, Magrin S et al. Activation of the complement system in primary sclerosing cholangitis. Gastroenterology 1989;97:1430-4.
2. Bodenheimer HC, LaRusso NF, Thayer WR, Charland C, Staples PJ, Ludwig J. Elevated circulating immune complexes in primary sclerosing cholangitis. Hepatology 1983;3:150-4.
3. Angulo P, Lindor KD. Primary Sclerosing Cholangitis. Hepatology 1999;30:325-32.
4. Lo SK, Fleming KA, Chapman RW. Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitits using an alkaline phosphatase technique. Gut 1992;33:1370-5.
5. Mulder AH, Horst G, Haagsma EB, Limburg PC, Kleinbeuker JH, Kallenberg CG. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology 1993;17:411-7.
6. Angulo P, Peter JB, Gershwin ME et al. Serum autoantibodies in patients with primary sclerosing cholangitis. J Hepatol 2000;32:182-7.
7. Lo SK, Fleming KA, Chapman RW. A 2-year follow-up study of anti-neutrophil antibody in primary sclerosing cholangitis: relationship to clinical activity, liver biochemistry and ursodeoxycholic acid treatment. J Hepatol 1994;21:974-8.
8. Bo X, Broome U, Remberger M, Sumitran-Holgersson S. Tumour necrosis factor alpha impairs function of liver derived T lymphocytes and natural killer cells in patients with primary sclerosing cholangitis. Gut 2001;49:131-41.
9. Bromme U, Eriksson LS, Sundin U, Sundqvist KG. Decreased in vitro production of tumor necrosis factor in primary biliary cirrhosis patients. Scand J Gastroenterol 1992;27:124-8.
10. Whiteside TL, Lasky S, Si L, Van Thiel DH. Immunologic analysis of mononuclear cells in liver tissues and blood of patients with primary sclerosing cholangitis. Hepatology 1985;5:468-74.
11. Chapman RW, Arborgh BA, Rhodes JM et al. Primary sclerosing cholangitis - a review of its clinical features, cholangiography and hepatic histology. Gut 1980;21:870-7.
12. Ponsioen CIJ, Tytgat GNJ. Primary sclerosing cholangitis: a clinical review. Am J Gastroenterol 1998;93:515-23.
13. Kono K, Ohnishi K, Omata M et al. Experimental portal fibrosis produced by intraportal injection of killed nonpathogenic Escherichia coli in rabbits. Gastroenterology 1988;94:787-96.
14. Lichtman SN, Okoruwa EE, Keku J, Schwab JH, Sartor RB. Degradation of endogenous bacterial wall polymers by the muralytic enzyme mutanolysin prevents hepatobiliary injury in genetically susceptible rats with experimental intestinal bacterial overgrowth. J Clin Invest 1992;90:1313-22.
15. Lichtman SN, Keku J, Clark RL, Schwab JH, Sartor RB. Biliary tract disease in rats with experimental small bowel bacterial overgrowth. Hepatology 1991;13:766-72.
16. Ueno Y, Phillips JO, Ludwig J, Lichtman SN, LaRusso NF. Development and characterization of a rodent model of immune-mediated cholangitis. Proc Natl Acad Sci USA 1996;93:216-20.
17. Yamada S, Ishii M, Liang LS, Yamamoto T, Toyota T. Small duct cholangitis induced by N-formyl L-methionine L-leucin L-tyrosine in rats. J Gastroenterol 1994;29:631-6.
18. Mourelle M, Salas A, Vilaseca J, Guarner F, Malagelada JR. Induction of chronic cholangitis in the rat by trinitrobenzenesulfonic acid. J Hepatol 1995;22:219-25.
19. Orth T, Neurath M, Schirmacher P, Treichel U, Meyer zum Büschenfelde K-H, Mayet W-J. Anti-neutrophil cytoplasmic antibodies in a rat model of trinitrobenzenesulphonic acid-induced liver injury. Eur J Clin Invest 1999;29:929-39.
20. Orth T, Neurath M, Schirmacher P, Galle PR, Mayet W-J. A novel rat model of chronic fibrosing cholangitis induced by local administration of a hapten reagent into the dilated bile duct is associated with increased TNF-alpha production and autoantibodies. J Hepatol 2000;33:862-72.
21. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989;96:795-803.
22. Rodriguez-Garay EA, Agüero RM, Pisani G, Trbojevich RA, Farroni A, Vigilanco RA. Rat model of mild stenosis of the common bile duct. Res Exp Med 1996;196:105-16.
23. Bemelmans MH, Greve JW, Gouma DJ, Buurman WA. Increased concentrations of tumour necrosis factor (TNF) and soluble TNF receptors in biliary obstruction in mice; soluble TNF receptors as prognostic factors for mortality. Gut 1996;38:447-53.
24. Mano Y, Ishii M, Okamoto H, Igarashi T, Kobayashi K, Toyota T. Effect of tumor necrosis factor alpha on intrahepatic bile duct epithelial cell of rat liver. Hepatology 1996;23:1602-7.
25. Ayres RC, Neuberger JM, Shaw J, Joplin R, Adams DH. Intercellular adhesion molecule-1 and MHC antigens on human intrahepatic bile duct cells: effect of proinflammatory cytokines. Gut 1993;34:1245-9.
26. Osborn L, Hession C, Tizard R et al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 1989;59:1203-11.
27. Houdijk AP, Boermeester MA, Wesdorp RI, Hack CE, Van Leeuwen PA. Tumor necrosis factor unresponsiveness after surgery in bile duct-ligate rats. Am J Physiol 1996;27:G980-6.
28. Bansi DS, Bauducci M, Bergqvist A et al. Detection of antineutrophil antibodies in primary sclerosing cholangitis: a comparison of the alkaline phophatase and immunofluorescent techniques. Eur J Gastroenterol Hepatol 1997;9:575-80.
29. Geier A, Dietrich CG, Lammert F et al. Regulation of organic anion transporters in a new rat model of acute and chronic cholangitis resembling human primary sclerosing cholangitis. J Hepatol 2002;36: 718-24.
30. Ehrhardt RO, Ludviksson BJ, Gray B, Neurath M, Strober W. Induction and prevention of colonic inflammation in IL-2-deficient mice. J Immunol 1997;158:566-73.